Ir para o conteúdo
VuFind
  • A sua conta
  • Sair
  • Entrar
  • Idioma
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português (Brasil)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
Avançada
  • Refinement of prognosis and th...
  • Exemplares
  • Citar
  • Enviar por email
  • Imprimir
  • Exportar registo
    • Exportar para RefWorks
    • Exportar para EndNoteWeb
    • Exportar para EndNote
    • Exportar para BibTeX
    • Exportar para RIS
  • Adic. favoritos
A carregar...

Código QR

Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Cancer J
Main Authors: Liapis, Konstantinos, Papadopoulos, Vasileios, Vrachiolias, George, Galanopoulos, Athanasios G., Papoutselis, Menelaos, Papageorgiou, Sotirios G., Diamantopoulos, Panagiotis T., Pappa, Vassiliki, Viniou, Nora-Athina, Kourakli, Alexandra, Τsokanas, Dimitris, Vassilakopoulos, Theodoros P., Hatzimichael, Eleftheria, Bouronikou, Eleni, Ximeri, Maria, Pontikoglou, Charalambos, Megalakaki, Aekaterini, Zikos, Panagiotis, Panayiotidis, Panayiotis, Dimou, Maria, Karakatsanis, Stamatis, Papaioannou, Maria, Vardi, Anna, Kontopidou, Flora, Harchalakis, Nikolaos, Adamopoulos, Ioannis, Symeonidis, Argiris, Kotsianidis, Ioannis
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Correspondence
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7878783/
https://ncbi.nlm.nih.gov/pubmed/33574231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-021-00424-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
  • Exemplares
  • Descrição
  • Comentários
  • Previsualização
  • Registos relacionados
  • Registo fonte

Registos relacionados

  • Azacytidine Failure Revisited: an Appraisal Based on Real-Life Data from the MDS Registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS)
    Por: Kotsianidis, Ioannis, et al.
    Publicado em: (2019)
  • The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry
    Por: Diamantopoulos, Panagiotis, et al.
    Publicado em: (2019)
  • Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes
    Por: Papageorgiou, Sotirios G., et al.
    Publicado em: (2020)
  • Blood and platelet transfusion from a donor with presymptomatic Covid-19
    Por: Liapis, Konstantinos, et al.
    Publicado em: (2020)
  • Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein–Barr virus‐positive patients with chronic lymphocytic leukemia
    Por: Diamantopoulos, Panagiotis T., et al.
    Publicado em: (2016)

Opções de Pesquisa

  • Histórico de Pesquisas
  • Pesquisa Avançada

Encontrar Mais

  • Percorrer o Catálogo
  • Percorrer por ordem alfabética
  • Explore Channels
  • Bibliografia Recomendada
  • Novos exemplares

Precisa de ajuda?

  • Dicas de Pesquisa
  • Serviço de Referência
  • FAQs
A carregar...